Anonymous (1992) Facing up to the problem of non-compliance in schizophrenia. Curr Ther33: 69-72
2.
Baldessarini R.J. (1985) Drugs and the treatment of psychiatric disorders . In Goodman Gilman A, Goodman L S, Rall T, Murad F (eds) The pharmacological basis of therapeutics7th edn. Macmillan Publishing Company, New York, pp. 387-445
Harrow M., Fichter C.G., Grossman L.S., Yonan C.A., Sands J. (1991) Neuroleptic depression in schizophrenia. Biol Psychiatr30: 844-848
6.
Hogan T.P., Awad A.G., Eastwood M.R. (1983) A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med13: 177-183
7.
Hogan T.P., Awad A.G., Eastwood M.R. (1985) Early subjective response and prediction of outcome to neuroleptic drug therapy in schizophrenia. Can J Psychiatr30: 246-248
8.
Hollister LE (1992) Neuroleptic dysphoria: so what's new? Biol Psychiatr31: 531-537
9.
Nelson A. (1975) Drug default among schizophrenic patients. Am J Hosp Pharm32: 1237-1242
10.
Sandell B., Eriksson L. (1992) Patient experience with remoxipride—results contributed by patients in group meetings and individual interviews. Presented at the XVIII CINP Congress, Nice , June 1992
11.
Van Putten T., May P R A, Marder S.R. (1984) Response to antipsychotic medication: the doctor's and the consumer's view. Am J Psychiatr141: 16-19
